Femasys (FEMY) News Today $0.98 +0.09 (+10.15%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2024 EPS Estimates for Femasys Decreased by AnalystNovember 20 at 2:25 AM | americanbankingnews.comFY2024 EPS Estimates for Femasys Decreased by HC WainwrightNovember 17, 2024 | americanbankingnews.comFemasys’s Strategic Growth: Innovative Product Launches and Expansions in Women’s HealthNovember 15, 2024 | markets.businessinsider.comPromising Outlook for Femasys Amid Strategic Partnerships and Product AdvancementsNovember 13, 2024 | markets.businessinsider.comFemasys price target lowered to $8 from $10 at ChardanNovember 13, 2024 | msn.comFemasys’s Strong U.S. Launch and International Expansion Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comFemasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comFemasys to Exhibit at the Annual AAGL 2024 Global ConferenceNovember 8, 2024 | markets.businessinsider.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 2, 2024 | theglobeandmail.comFemasys issued U.S. patent covering FemBloc deviceNovember 2, 2024 | msn.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 1, 2024 | globenewswire.comFemasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeedOctober 31, 2024 | finance.yahoo.comStrategic Partnerships and Market Potential Drive Positive Outlook for FemaSeed Amidst RisksOctober 31, 2024 | markets.businessinsider.comFemasys announces partnership with Boston IVFOctober 31, 2024 | markets.businessinsider.comFemasys Advances in Women’s Health InnovationOctober 29, 2024 | markets.businessinsider.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education ProgramOctober 10, 2024 | finance.yahoo.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education ProgramOctober 10, 2024 | globenewswire.comFemasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | globenewswire.comFemasys Announces Infertility Clinic Customers from Coast to CoastSeptember 18, 2024 | globenewswire.comFemasys’s Strategic Expansion and Market Potential Bolster Buy RatingSeptember 13, 2024 | markets.businessinsider.comFemasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)September 12, 2024 | benzinga.comFemasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish MarketSeptember 11, 2024 | globenewswire.comFemasys Receives 510(k) Clearance From FDA To Market FemChec For Fallopian Tube DiagnosisSeptember 10, 2024 | markets.businessinsider.comFemasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube CheckSeptember 9, 2024 | globenewswire.comFemasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual MeetingSeptember 5, 2024 | markets.businessinsider.comFemasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual MeetingSeptember 5, 2024 | globenewswire.comFemasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comFemasys Inc.: Femasys Announces CE Mark and Canadian Approval for FemVue MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | finanznachrichten.deFemasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | globenewswire.comFemasys Hosts Congresswoman Lucy McBath at Georgia HeadquartersAugust 27, 2024 | globenewswire.comFemasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateAugust 8, 2024 | globenewswire.comFemasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in AmsterdamJune 27, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeMay 17, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeMay 17, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy CouncilMay 16, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Gender Policy CouncilMay 16, 2024 | globenewswire.comFemasys’s Buy Rating Affirmed by Analyst Jason McCarthy on FemaSeed’s Market Success and Robust Clinical TrialsMay 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)May 9, 2024 | markets.businessinsider.comFEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024May 9, 2024 | investorplace.comFemasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate UpdateMay 9, 2024 | globenewswire.comFemasys Expands Commercial Management Team with Addition of Experienced New HiresMay 7, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesApril 18, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare InitiativesApril 18, 2024 | globenewswire.comFemasys (FEMY) Price Target Increased by 5.41% to 9.95April 17, 2024 | msn.comFemasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 31, 2024 | finance.yahoo.comFEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023March 28, 2024 | investorplace.comFemasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comAnalysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)March 21, 2024 | markets.businessinsider.com Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. FEMY Media Mentions By Week FEMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼-0.560.45▲Average Medical News Sentiment FEMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼91▲FEMY Articles Average Week Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LENSAR News Vivani Medical News Modular Medical News Monogram Orthopaedics News InspireMD News Hyperfine News electroCore News Alpha Pro Tech News Lucid Diagnostics News Nutriband News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FEMY Stock Alerts